查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1939278

2026年全球人工器官和医用仿生学市场报告

Artificial Vital Organs And Medical Bionics Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，人工器官和医用仿生学市场经历了显着增长，预计将从2025年的469.5亿美元增长到2026年的510.7亿美元，复合年增长率为8.8%。成长要素包括人工器官技术的应用有限、早期仿生设备高成本、对机械器官系统的依赖、器官衰竭的趋势日益加剧以及医用仿生设备监管核准的提前。

预计未来几年，人工重要器官和医用仿生学市场将保持强劲成长，到2030年市场规模将达到706.7亿美元，复合年增长率（CAGR）为8.5%。预测期内的成长要素包括电子和智慧仿生设备的进步、人工器官研发投入的增加、微创移植手术的日益普及、个人化医疗和患者客製化解决方案的发展，以及提供仿生疗法的医院和诊所数量的增长。预测期内的主要趋势包括人工心臟和肾臟设备的日益普及、神经植入与仿生器官的融合度不断提高、復健和辅助技术的发展、对可客製化患者客製化解决方案的关注，以及临床试验和研究性应用的扩展。

预计未来器官衰竭发生率的上升将推动人工重要器官和医用仿生学市场的成长。器官衰竭是一种严重的疾病，指一个或多个器官丧失其基本功能，可能导致严重的健康併发症和危及生命的后果。器官衰竭发生率的上升是由糖尿病、高血压和心臟病等慢性疾病以及遗传性疾病和易感因素等因素共同导致的。人工重要器官和医用仿生学透过为器官受损患者提供生命维持和恢復其重要功能来帮助控制器官衰竭。例如，根据总部位于美国的非营利器官捐赠和移植系统－器官取得和移植网络（OPTN）的数据，截至2025年1月，2024年进行的器官移植数量将超过48,000例，比2023年增加3.3%。因此，器官衰竭发生率的上升趋势正在推动人工重要器官和医用仿生学市场的成长。

预计未来社会老化将推动人工重要器官和医用仿生技术市场的成长。老年人口指的是60岁或65岁以上的人。与老龄化相关的健康和生活方式挑战需要个人化的照护和服务。随着医疗保健系统的改善和生活水准的提高，预期寿命的延长导致老年人口不断增长。人工重要器官和医用仿生技术可以透过替代或增强衰退的生物功能来帮助老年人，提高他们的行动能力、独立性和整体生活品质。例如，根据美国非营利组织人口研究所（Population Research Institute）2024年1月发布的报告（该机构收集统计数据用于研究和学术用途），预计美国65岁及以上人口将从2022年的5800万增长到2050年的8200万，增幅达47%。因此，同期该年龄组占美国总人口的比例将从17%上升到23%。因此，人口老化加剧推动了人造器官和医用仿生学市场的成长。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球人工器官及医用仿生学市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 人工智慧（AI）和自主人工智慧
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 自主系统、机器人与智慧运输
  • 主要趋势
    • 人工心臟和肾臟装置的应用日益普及
    • 神经植入与仿生器官融合技术的进展
    • 復健和辅助科技的发展
    • 专注于可自订的、特异性患者的解决方案
    • 扩大临床试验与研究应用

第五章 终端用户产业市场分析

  • 医院
  • 诊所
  • 復健中心
  • 研究所
  • 医疗设备製造商

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球人工器官和医用仿生市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球人工器官及医用仿生学市场规模、对比及成长率分析
  • 全球人工器官和医用仿生学市场表现：规模和成长，2020-2025年
  • 全球人工器官和医用仿生学市场预测：规模和成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 按类型
  • 人工生命器官，医学仿生学
  • 透过技术
  • 机械、电子
  • 透过使用
  • 医院、诊所和其他用途
  • 依类型细分：人工生命器官
  • 人工心臟、人工肾臟、人工肝、人工肺、人工胰腺
  • 按类型细分：医疗仿生学
  • 仿生肢体、仿生眼、仿生耳、神经植入、仿生器官

第十章 区域与国家分析

  • 全球人工器官及医用仿生学市场：区域表现及预测，2020-2025年、2025-2030年预测、2035年预测
  • 全球人工器官及医用仿生学市场：国家、市场表现及预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第三十六章：竞争格局与公司概况

  • 人工器官和医用仿生市场：竞争格局和市场份额，2024 年
  • 人工器官与医用仿生市场：公司估值矩阵
  • 人工器官和医用仿生学市场：公司概况
    • Abiomed Inc.
    • Abbott Laboratories
    • Medtronic Plc
    • Fresenius Medical Care AG
    • Asahi Kasei Corporation

第37章：其他领先和创新企业

  • Boston Scientific Corporation, Biomet Inc., Terumo Corporation, Edwards Lifesciences Corporation, Otto Bock Healthcare GmbH, Nikkiso Co. Ltd., Cochlear Ltd., Ossur, Cirtec Medical, Heartware International Inc., Berlin Heart GmbH, SynCardia Systems LLC, Ekso Bionics Holdings Inc., Jarvik Heart Inc., CARMAT

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年人工器官和医用仿生市场：提供新机会的国家
  • 2030年人工器官与医用仿生市场：充满新机会的细分市场
  • 2030年人工器官与医用仿生市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MAVOM01_G26Q1

Artificial vital organs are engineered devices that replicate the function of essential organs, while medical bionics integrates biological and electronic systems to restore or enhance bodily functions. The primary aim is to sustain life, improve quality of life in cases of severe organ failure, and help recover or enhance lost physical abilities.

The key artificial vital organs and medical bionics consist of artificial vital organs and medical bionics. Artificial vital organs are technologically developed devices that mimic the functions of natural organs such as the heart, lungs, or kidneys to support life in patients experiencing organ failure. These systems may be mechanical or electronic in nature and are commonly used by hospitals, clinics, and other healthcare providers.

Tariffs are impacting the artificial vital organs and medical bionics market by increasing the cost of imported components, such as electronic sensors, mechanical pumps, and specialized biomaterials. Segments like electronic medical bionics and artificial heart devices are particularly impacted, with Asia-Pacific regions including China and India facing higher import duties. This has raised production and procurement costs while causing temporary supply chain disruptions. Positively, tariffs have encouraged local manufacturing, innovation in material sourcing, and investment in domestic production capacities to reduce dependency on imports.

The artificial vital organs and medical bionics market research report is one of a series of new reports from The Business Research Company that provides artificial vital organs and medical bionics market statistics, including artificial vital organs and medical bionics industry global market size, regional shares, competitors with a artificial vital organs and medical bionics market share, detailed artificial vital organs and medical bionics market segments, market trends and opportunities, and any further data you may need to thrive in the artificial vital organs and medical bionics industry. This artificial vital organs and medical bionics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial vital organs and medical bionics market size has grown strongly in recent years. It will grow from $46.95 billion in 2025 to $51.07 billion in 2026 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to limited availability of artificial organ technologies, high cost of early bionic devices, reliance on mechanical organ systems, increasing prevalence of organ failure, initial regulatory approvals for medical bionic devices.

The artificial vital organs and medical bionics market size is expected to see strong growth in the next few years. It will grow to $70.67 billion in 2030 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to advancements in electronic and smart bionic devices, rising investment in r&d for artificial organs, increasing adoption of minimally invasive implantation procedures, growth in personalized medicine and patient-specific solutions, expansion of hospitals and clinics offering bionic therapies. Major trends in the forecast period include rising adoption of artificial heart and kidney devices, increasing integration of neural implants and bionic organs, growth in rehabilitation and assistive technologies, emphasis on customizable and patient-specific solutions, expansion of clinical trials and research applications.

The rising prevalence of organ failures is expected to propel the growth of the artificial vital organs and medical bionics market going forward. Organ failure is a serious condition in which one or more organs lose their ability to perform essential functions, resulting in severe health complications and potentially life-threatening outcomes. The increase in organ failures is driven by higher rates of chronic conditions such as diabetes, hypertension, and heart disease, as well as inherited conditions and genetic predispositions that contribute to organ failure. Artificial vital organs and medical bionics help manage organ failure by providing life-sustaining support and restoring critical functions in patients with damaged organs. For instance, in January 2025, according to the Organ Procurement and Transplantation Network, a US-based non-profit scientific organ donation and transplantation system, organ transplants exceeded 48,000 in 2024, representing a 3.3% increase from those performed in 2023. Therefore, the rising prevalence of organ failures is driving the growth of the artificial vital organs and medical bionics market.

The rise in the elderly population is expected to drive the growth of the artificial vital organs and medical bionics market going forward. The elderly population consists of individuals aged 60 or 65 and above who require customized care and services due to aging-related health and lifestyle challenges. The elderly population is increasing due to longer life expectancy supported by improved healthcare systems and better living standards. Artificial vital organs and medical bionics support the elderly population by replacing or enhancing declining biological functions, thereby improving mobility, independence, and overall quality of life. For example, in January 2024, according to a report published by Population Reference Bureau, a US-based non-profit organization responsible for collecting statistical data for research and academic use, the number of Americans aged 65 and older is expected to grow from 58 million in 2022 to 82 million by 2050, reflecting a 47% increase. As a result, this age group's share of the total US population will rise from 17% to 23% during this timeframe. Therefore, the increase in the elderly population is driving the growth of the artificial vital organs and medical bionics market.

Major companies operating in the artificial vital organs and medical bionics market are developing advanced products, such as bionic pancreas systems, to improve patient outcomes and meet the increasing demand for innovative medical solutions. A bionic pancreas is a sophisticated medical device designed to automate blood glucose regulation in individuals with diabetes by replicating the functions of a healthy pancreas. For example, in December 2023, Beta Bionics Inc., a US-based medical technology company, launched the iLet Bionic Pancreas, an autonomous insulin delivery system that simplifies diabetes management by automatically adjusting insulin delivery based on the user's weight. This approach removes the need for healthcare providers to configure complex settings such as insulin-to-carbohydrate ratios, correction factors, or preset basal rates, thereby reducing the burden on both patients and clinicians.

Major companies operating in the artificial vital organs and medical bionics market are Abiomed Inc., Abbott Laboratories, Medtronic Plc, Fresenius Medical Care AG, Asahi Kasei Corporation, Boston Scientific Corporation, Biomet Inc., Terumo Corporation, Edwards Lifesciences Corporation, Otto Bock Healthcare GmbH, Nikkiso Co. Ltd., Cochlear Ltd., Ossur, Cirtec Medical, Heartware International Inc., Berlin Heart GmbH, SynCardia Systems LLC, Ekso Bionics Holdings Inc., Jarvik Heart Inc., CARMAT, Iwalk Inc., BiVACOR Inc., Nano Retina Inc., Second Sight Medical Products Inc., St. Jude Medical Inc.

North America was the largest region in the artificial vital organs and medical bionics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial vital organs and medical bionics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial vital organs and medical bionics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The artificial vital organs and medical bionics market consists of sales of artificial hearts, artificial kidneys, artificial lungs, artificial pancreas, bionic limbs, cochlear implants, retinal implants, neuroprosthetics. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Vital Organs And Medical Bionics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses artificial vital organs and medical bionics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial vital organs and medical bionics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial vital organs and medical bionics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Artificial Vital Organs; Medical Bionics
  • 2) By Technology: Mechanical; Electronic
  • 3) By Application: Hospitals; Clinics; Other Applications
  • Subsegments:
  • 1) By Artificial Vital Organs: Artificial Heart; Artificial Kidney; Artificial Liver; Artificial Lungs; Artificial Pancreas
  • 2) By Medical Bionics: Bionic Limbs; Bionic Eyes; Bionic Ears; Neural Implants; Bionic Organs
  • Companies Mentioned: Abiomed Inc.; Abbott Laboratories; Medtronic Plc; Fresenius Medical Care AG; Asahi Kasei Corporation; Boston Scientific Corporation; Biomet Inc.; Terumo Corporation; Edwards Lifesciences Corporation; Otto Bock Healthcare GmbH; Nikkiso Co. Ltd.; Cochlear Ltd.; Ossur; Cirtec Medical; Heartware International Inc.; Berlin Heart GmbH; SynCardia Systems LLC; Ekso Bionics Holdings Inc.; Jarvik Heart Inc.; CARMAT; Iwalk Inc.; BiVACOR Inc.; Nano Retina Inc.; Second Sight Medical Products Inc.; St. Jude Medical Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Artificial Vital Organs And Medical Bionics Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Artificial Vital Organs And Medical Bionics Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Artificial Vital Organs And Medical Bionics Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Artificial Vital Organs And Medical Bionics Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Autonomous Systems, Robotics & Smart Mobility
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Artificial Heart And Kidney Devices
    • 4.2.2 Increasing Integration Of Neural Implants And Bionic Organs
    • 4.2.3 Growth In Rehabilitation And Assistive Technologies
    • 4.2.4 Emphasis On Customizable And Patient-Specific Solutions
    • 4.2.5 Expansion Of Clinical Trials And Research Applications

5. Artificial Vital Organs And Medical Bionics Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Clinics
  • 5.3 Rehabilitation Centers
  • 5.4 Research Institutions
  • 5.5 Medical Device Manufacturers

6. Artificial Vital Organs And Medical Bionics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Artificial Vital Organs And Medical Bionics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Artificial Vital Organs And Medical Bionics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Artificial Vital Organs And Medical Bionics Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Artificial Vital Organs And Medical Bionics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Artificial Vital Organs And Medical Bionics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Artificial Vital Organs And Medical Bionics Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Artificial Vital Organs And Medical Bionics Market Segmentation

  • 9.1. Global Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Artificial Vital Organs, Medical Bionics
  • 9.2. Global Artificial Vital Organs And Medical Bionics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Mechanical, Electronic
  • 9.3. Global Artificial Vital Organs And Medical Bionics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Clinics, Other Applications
  • 9.4. Global Artificial Vital Organs And Medical Bionics Market, Sub-Segmentation Of Artificial Vital Organs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Artificial Heart, Artificial Kidney, Artificial Liver, Artificial Lungs, Artificial Pancreas
  • 9.5. Global Artificial Vital Organs And Medical Bionics Market, Sub-Segmentation Of Medical Bionics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Bionic Limbs, Bionic Eyes, Bionic Ears, Neural Implants, Bionic Organs

10. Artificial Vital Organs And Medical Bionics Market Regional And Country Analysis

  • 10.1. Global Artificial Vital Organs And Medical Bionics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Artificial Vital Organs And Medical Bionics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Artificial Vital Organs And Medical Bionics Market

  • 11.1. Asia-Pacific Artificial Vital Organs And Medical Bionics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Artificial Vital Organs And Medical Bionics Market

  • 12.1. China Artificial Vital Organs And Medical Bionics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Artificial Vital Organs And Medical Bionics Market

  • 13.1. India Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Artificial Vital Organs And Medical Bionics Market

  • 14.1. Japan Artificial Vital Organs And Medical Bionics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Artificial Vital Organs And Medical Bionics Market

  • 15.1. Australia Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Artificial Vital Organs And Medical Bionics Market

  • 16.1. Indonesia Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Artificial Vital Organs And Medical Bionics Market

  • 17.1. South Korea Artificial Vital Organs And Medical Bionics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Artificial Vital Organs And Medical Bionics Market

  • 18.1. Taiwan Artificial Vital Organs And Medical Bionics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Artificial Vital Organs And Medical Bionics Market

  • 19.1. South East Asia Artificial Vital Organs And Medical Bionics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Artificial Vital Organs And Medical Bionics Market

  • 20.1. Western Europe Artificial Vital Organs And Medical Bionics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Artificial Vital Organs And Medical Bionics Market

  • 21.1. UK Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Artificial Vital Organs And Medical Bionics Market

  • 22.1. Germany Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Artificial Vital Organs And Medical Bionics Market

  • 23.1. France Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Artificial Vital Organs And Medical Bionics Market

  • 24.1. Italy Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Artificial Vital Organs And Medical Bionics Market

  • 25.1. Spain Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Artificial Vital Organs And Medical Bionics Market

  • 26.1. Eastern Europe Artificial Vital Organs And Medical Bionics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Artificial Vital Organs And Medical Bionics Market

  • 27.1. Russia Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Artificial Vital Organs And Medical Bionics Market

  • 28.1. North America Artificial Vital Organs And Medical Bionics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Artificial Vital Organs And Medical Bionics Market

  • 29.1. USA Artificial Vital Organs And Medical Bionics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Artificial Vital Organs And Medical Bionics Market

  • 30.1. Canada Artificial Vital Organs And Medical Bionics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Artificial Vital Organs And Medical Bionics Market

  • 31.1. South America Artificial Vital Organs And Medical Bionics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Artificial Vital Organs And Medical Bionics Market

  • 32.1. Brazil Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Artificial Vital Organs And Medical Bionics Market

  • 33.1. Middle East Artificial Vital Organs And Medical Bionics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Artificial Vital Organs And Medical Bionics Market

  • 34.1. Africa Artificial Vital Organs And Medical Bionics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Artificial Vital Organs And Medical Bionics Market Regulatory and Investment Landscape

36. Artificial Vital Organs And Medical Bionics Market Competitive Landscape And Company Profiles

  • 36.1. Artificial Vital Organs And Medical Bionics Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Artificial Vital Organs And Medical Bionics Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Artificial Vital Organs And Medical Bionics Market Company Profiles
    • 36.3.1. Abiomed Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Fresenius Medical Care AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Asahi Kasei Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Artificial Vital Organs And Medical Bionics Market Other Major And Innovative Companies

  • Boston Scientific Corporation, Biomet Inc., Terumo Corporation, Edwards Lifesciences Corporation, Otto Bock Healthcare GmbH, Nikkiso Co. Ltd., Cochlear Ltd., Ossur, Cirtec Medical, Heartware International Inc., Berlin Heart GmbH, SynCardia Systems LLC, Ekso Bionics Holdings Inc., Jarvik Heart Inc., CARMAT

38. Global Artificial Vital Organs And Medical Bionics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Artificial Vital Organs And Medical Bionics Market

40. Artificial Vital Organs And Medical Bionics Market High Potential Countries, Segments and Strategies

  • 40.1 Artificial Vital Organs And Medical Bionics Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Artificial Vital Organs And Medical Bionics Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Artificial Vital Organs And Medical Bionics Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer